Regal Assets Analytics

SanaCurrents Following Stock Highs After Coronavirus Developments

By |2020-05-05T08:58:49-04:00May 4th, 2020|Tags: |

Last Friday, the FDA granted emergency use authorization (EUA) to Gilead Sciences, Inc. (NASDAQ:GILD) remdesivir to treat patients hospitalized with [...]

New Approaches to Alzheimer’s After a String of Failures

By |2020-10-20T14:52:53-04:00April 26th, 2019|Tags: |

Did you ever wonder how a company like Biogen, valued at approximately $68 billion earlier this year, could lose one-third [...]

Evolus & Urovant: Similar Strategies, Opposite Reactions to Positive Catalysts

By |2019-03-25T11:45:49-04:00March 25th, 2019|Tags: , , , , |

One of the strongest performing biopharmaceutical stocks this year is Evolus (EOLS).  When the FDA on February 1 approved the [...]

Go to Top